상세정보
Export to Refworks부가기능
Metformin Pharmacogenomics: Functional Genomics of CDC25b and TPD54 Regulation of Metformin Anticancer Response in Breast Cancer
상세 프로파일
| 자료유형 | 학위논문 |
|---|---|
| 서명/저자사항 | Metformin Pharmacogenomics: Functional Genomics of CDC25b and TPD54 Regulation of Metformin Anticancer Response in Breast Cancer. |
| 개인저자 | Ly, Reynold. |
| 단체저자명 | College of Medicine - Mayo Clinic. Molecular Pharmacology and Experimental Therapeutics. |
| 발행사항 | [S.l.]: College of Medicine - Mayo Clinic., 2018. |
| 발행사항 | Ann Arbor: ProQuest Dissertations & Theses, 2018. |
| 형태사항 | 250 p. |
| 기본자료 저록 | Dissertation Abstracts International 79-12B(E). Dissertation Abstract International |
| ISBN | 9780438267589 |
| 학위논문주기 | Thesis (Ph.D.)--College of Medicine - Mayo Clinic, 2018. |
| 일반주기 |
Source: Dissertation Abstracts International, Volume: 79-12(E), Section: B.
Adviser: Liewei Wang. |
| 요약 | Metformin, a type II diabetic drug, is a promising agent in the treatment of cancer. However, the molecular mechanism of anticancer action is not fully understood. In this thesis, we will describe the pharmacogenomics approach used to identify g |
| 일반주제명 | Pharmacology. Oncology. Genetics. |
| 언어 | 영어 |
| 바로가기 | 
: 이 자료의 원문은 한국교육학술정보원에서 제공합니다. |
